Bibliographic Info
GuidelineWHO Guidelines for malaria, 14 March 2023
Year of Publication2023
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
Artesunate-pyronaridine for uncomplicated malaria: Artesunate-pyronaridine (ASPY) is recommended as an artemisinin-based combination therapy option for the treatment of uncomplicated P. falciparum malaria.
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 October 2023.
Year2023
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 30 November 2024.
Year2024
InstitutionWHO